Form 4: Calix CEO Sells Shares Under Pre-Arranged 10b5-1 Plan

Calix President & CEO Michael Weening sold a total of 176,000 shares of common stock in September 2025, following the exercise of stock options, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Michael Weening, President & CEO and Director of Calix, Inc. (CALX), reported transactions involving the company's common stock and stock options.
• On September 10, 2025, Mr. Weening exercised options to acquire 150,000 shares of common stock at an exercise price of $7.84 per share and simultaneously sold 150,000 shares of common stock at a price of $62.00 per share.
• Also on September 10, 2025, he exercised options for an additional 7,990 shares at $7.84 per share and sold these 7,990 shares at $63.00 per share.
• On September 11, 2025, Mr. Weening exercised options for 18,010 shares at $7.84 per share and sold these 18,010 shares at $63.00 per share.
• All reported sales were executed pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
• Following these transactions, Mr. Weening directly beneficially owns 16,117 shares of common stock and 274,000 stock options.
• The stock options exercised were fully vested and exercisable as of November 27, 2023.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic timing. The significant profit realized by the executive also reflects positively on the company's stock performance.

Positives

• The transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled and non-discretionary sale, which often mitigates concerns about opportunistic insider selling.
• Mr. Weening realized significant gains by exercising options at a low price ($7.84) and selling shares at substantially higher market prices ($62.00 $63.00).

Negatives

• The sale of a significant number of shares (176,000) by a key executive, even if planned, could be perceived by some investors as a reduction in management's direct equity exposure.

Risks

• While executed under a 10b5-1 plan, the sale of shares by a high-ranking executive could still lead to negative market sentiment or speculation if not fully understood by investors, potentially causing short-term stock price volatility.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.

Industry Context

This filing is a standard insider transaction report and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual executive's equity management strategy.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan for insider sales is a common and accepted practice among executives in publicly traded companies across various industries, including technology and telecommunications, to manage personal finances while adhering to insider trading regulations. Companies like Cisco Systems, Juniper Networks, and Arista Networks often see similar planned sales from their executives.
• The significant profit realized from the option exercises and subsequent sales is typical for long-tenured executives whose equity compensation has appreciated with company growth, aligning with compensation structures seen in the broader tech sector.

Corporate Governance

Stakeholder Impact

• Shareholders: May observe the executive's reduction in direct shareholding, but the 10b5-1 plan context suggests a planned diversification or liquidity event rather than a lack of confidence.
• Employees: No direct impact mentioned, but executive share sales are generally monitored for signals about company health.

Next Steps

• No specific future actions or milestones for the company are mentioned in this insider transaction report.

Key Dates

Recommendation

This Form 4 filing details planned insider sales by the CEO, executed under a Rule 10b5-1 trading plan. While the sale of a significant number of shares by an executive can sometimes be a cause for concern, the pre-arranged nature of the transaction suggests it is for personal financial planning rather than a reaction to new, negative company information. The filing itself does not provide fundamental company performance data to warrant a 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position and look to broader company fundamentals and market conditions for investment decisions.

Keywords

CALX, Calix, Michael Weening, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, CEO, Director, Equity Sales